Detection of risk of pre-eclampsia

Abstract

A method for the early prediction of risk of hypertensive disorders in pregnant women, including for example eclampsia, mild pre-eclampsia, chronic hypertension, EPH gestosis, gestational hypertension, superimposed pre-eclampsia, HELLP syndrome, or nephropathy.

1 . A method of treatment of pre-eclampsia in a pregnant woman comprising administering clinical intervention to the pregnant woman previously identified as being at increased risk of developing pre-eclampsia, wherein the pregnant woman is previously identified as being at increased risk of developing pre-eclampsia by assaying a biological sample from the pregnant woman to determine an abundance of Di-(octadecadienoyl)-sn-glycerol relative to a reference abundance, and wherein an increased abundance of Di-(octadecadienoyl)-sn-glycerol relative to the reference abundance is detected. 
     
     
         2 . A method as claimed in  claim 1 , wherein the clinical intervention comprises administering an anti-hypertensive medicament to the pregnant woman.